Effect of octreotide pretreatment on surgical outcome in acromegaly

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 10, 1997, Pages 3308-3314

  Colao, Annamaria ^a   Ferone, Diego ^a   Cappabianca, Paolo ^a   Del Basso De Caro, Maria Laura ^a   Marzullo, Paolo ^a   Monticelli, Arianna ^a   Alfieri, Alessandra ^b   Merola, Bartolomeo ^a   Calì, Antonio ^a   De Divitiis, Enrico ^a   Lombardi, Gaetano ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GROWTH HORMONE; INSULIN; OCTREOTIDE; ORAL ANTIDIABETIC AGENT; SOMATOMEDIN C;

ACROMEGALY; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GLUCOSE HOMEOSTASIS; GROWTH HORMONE BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TRANSSPHENOIDAL SURGERY; TREATMENT OUTCOME;

EID: 9844264858     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.82.10.4283     Document Type: Article

References (21)

1. Jaffe CA, Barkan AL. 1994 Acromegaly. Recognition and treatment. Drugs. 47:425-445.
2. Melmed S, Ho K, Klibanski A, Reichlin S, Thorner MO. 1995 Recent advances in pathogenosis, diagnosis and management of acromegaly. J Clin Endocrinol Metab. 80:3395-3402.
3. Frohman LA. 1996 Acromegaly: what constitutes optimal therapy. J Clin Endocrinol Metab. 81:443-445.
4. Lamberts SWJ, van Der Lely A-J, De Herder WW, Hofland LJ. 1996 Octreotide. N Engl J Med. 334:246-254.
5. Melmed S, Dowling RH, Frohman L, et al. 1994 Consensus statement: benefits versus risks of medical therapy for acromegaly. Acromegaly Therapy Consensus Development Panel. Am J Med. 97:468-473.
6. Spinas GA, Zapf J, Landolt AM, Stuckmann G, Froesch ER. 1987 Pre-operative treatment of 5 acromegalics with a somatostatin analogue: endocrine and clinical observations. Acta Endocrinol (Copenh). 114:249-256.
7. Barkan A, Lloyd RV, Chandler WF, et al. 1988 Preoperative treatment of acromegaly with long-acting somatostatin analog SMS 201-995:shrinkage of invasive pituitary macroadenomas and improved surgical remission rate. J Clin Endocrinol Metab. 67:1040-1048.
8. Stevenaert A, Harris AG, Kovacs K, Beckers A. 1992 Presurgical octreotide treatment in acromegaly. Metabolism. 41:51-58.
9. Plockinger U, Reichel M, Fett U, Saeger W, Quabbe H-J. 1994 Preoperative octreotide treatment of growth hormone-secreting and clinically nonfunctioning pituitary macroadenomas: effects on tumor volume and lack of correlation with immunohistochemistry and somatostatin receptor scintigraphy. J Clin Endocrinol Metab. 79:1416-1423.
10. Ezzat S, Horvath E, Harris AG, Kovacs K. 1994 Morphological effects of octreotide on growth hormone-producing pituitary adenomas. J Clin Endocrinol Metab. 79:113-118.
11. Saccà L, Cittadini A, Fazio F. 1494 Growth hormone and the heart. Endocr Rev. 15:555-573.
12. Colao A, Ferone D, Lastoria S, et al. 1996 Prediction of efficacy of octreotide therapy in patients with acromegaly. J Clin Endocrinol Metab. 81:2356-2362.
13. Stevenaert A, Beckers A. 1996 Presurgical octreotide treatment in acromegaly. Metabolism. 45:72-74.
14. Thuesen L, Christensen SE, Weeke J, Orskov H, Henningsen P. 1989 The cardiovascular effects of octreotide treatment in acromegaly: an echocardiographic study. Clin Endocrinol (Oxf). 30:619-625.
15. Chanson P, Timsit J, Masquet C, et al. 1990 Cardiovascular effect of the somatostatin analog octreotide in acromegaly. Ann Intern Med. 113:921-923.
16. Pereira JL, Rodriguez-Puras MJ, Leal-Cerro A, et al. 1991 Acromegalic cardiopathy improves after treatment with increasing doses of octreotide. J Endocrinol Invest. 14:17-23.
17. Hradec J, Marek J, Kral J, Janota T, Poloniecki J, Malik M. 1993 Long-term echocardiographic follow-up of acromegalic heart disease. Am J Cardiol. 72:205-210.
18. Merola B, Cittadini A, Colao A, et al. 1993 Chronic treatment with the somatostatin analog octreotide improves cardiac abnormalities in acromegaly. J Clin Endocrinol Metab. 77:790-793.
19. Lombardi G, Colao A, Ferone D, et al. 1996 Cardiovascular aspects in acromegaly: effects of treatment. Metabolism. 45:57-60.
20. Koss LG. Diagnostic cytology and its histopathologic basis, 3rd ed. Philadelphia: Lippincot.
21. Hofland LJ, van Koetsveld PM, Wouters N, Waaijers M, Reubi J-C, Lamberts SWJ. 1992 Dissociation of antiproliferative and antihormonal effects of the somatostatin analog octreotide on 7315b pituitary tumor cells. Endocrinology. 131:571-577.